ASH President Responds to Administration’s Decision to End Cost Sharing Reduction Payments
(WASHINGTON, October 13, 2017) — American Society of Hematology (ASH) President Kenneth C. Anderson, MD, of the Dana-Farber Cancer Institute, issued the following statement in response to the Administration’s decision to end cost sharing reduction (CSR) payments to insurers.
“ASH is deeply disappointed in the Administration’s decision to end CSR payments to insurers. These payments are vital to reducing the out-of-pocket costs for enrollees in the marketplace, and ensure that people with rare and costly chronic blood diseases like sickle cell disease and blood cancers can receive the care they need. The decision to end these payments threatens the stability of the marketplace, and has the potential to raise health care costs for our most vulnerable patients. ASH calls on the Administration to reconsider this action, and urges the Senate to continue its ongoing efforts to find a bipartisan solution for rising health insurance costs and unstable markets nationwide.”
The American Society of Hematology (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.